文献速递毛发、甲与色素性疾病

斑秃:新治疗方法评价及现有治疗概述

Alopecia areata: An appraisal of new treatment approaches and overview of current therapies.
PubMed 文献 · J Am Acad Dermatol · 2018-01-01

许多局部、系统和注射疗法可用于斑秃,但临床结局不一且无治疗能诱导并维持缓解。临床决策需先按儿童与成人分层,再确定疾病严重程度(局限性与广泛性),之后决定最终治疗方案。本文评价Janus激酶抑制剂等新治疗方法的证据,包括疗效、副作用和持久性,并概述传统治疗及未来有前景但尚未充分评价的选项。

要点

  • 斑秃治疗包括局部、系统和注射方式,但临床结局不一,目前无治疗能诱导并维持缓解。
  • 管理决策需先按儿童与成人分层,再确定疾病严重程度(局限性与广泛性),之后决定最终治疗方案。
  • 本文评价Janus激酶抑制剂等新治疗的疗效、副作用和持久性证据,并概述传统治疗及未来有前景的选项。

核心结论

  • 许多疗法可用于斑秃治疗,但临床结局不一,目前无治疗能诱导并维持缓解。

研究设计与样本

  • 本文为继续医学教育系列第二篇文章,评价支持新治疗方法的证据并概述传统治疗。

主要发现

  • 许多局部、系统和注射疗法可用于斑秃,但临床结局不一且无治疗能诱导并维持缓解。

临床怎么用

  • 临床决策需先将患者分为儿童与成人群体,再确定疾病严重程度(局限性与广泛性),之后决定最终治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many therapies are available for the treatment of alopecia areata, including topical, systemic, and injectable modalities. However, these treatment methods produce variable clinical outcomes and there are no currently available treatments that induce and sustain remission. When making management decisions, clinicians must first stratify patients into pediatric versus adult populations. Disease severity should then be determined (limited vs extensive) before deciding the final course of therapy. The second article in this continuing medical education series describes the evidence supporting new treatment methods, among them Janus kinase inhibitors. We evaluate the evidence concerning the efficacy, side effects, and durability of these medications. An overview of conventional therapy is also provided with new insights gleaned from recent studies. Finally, future promising therapeutic options that have not yet been fully evaluated will also be presented.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Strazzulla LC, Wang EHC, Avila L, et al. Alopecia areata: An appraisal of new treatment approaches and overview of current therapies. J Am Acad Dermatol. 2018. PMID: 29241773. doi:10.1016/j.jaad.2017.04.1142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。